Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 1/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12477608 | 1.00 | OXER1 (0.38) | OXER1ALOX5ACLYPLA2G4A | |
| SCHEMBL11258153 | 0.88 | OXER1 (0.37) | OXER1ALOX5ACLY | |
| SCHEMBL11258147 | 0.88 | OXER1 (0.37) | OXER1ALOX5ACLY | |
| SCHEMBL11254307 | 0.88 | OXER1 (0.37) | OXER1ALOX5ACLY | |
| SCHEMBL11254309 | 0.88 | OXER1 (0.37) | OXER1ALOX5ACLY | |
| SCHEMBL12476952 | 0.82 | — | — | |
| SCHEMBL12476950 | 0.82 | — | — | |
| SCHEMBL3389158 | 0.82 | OXER1 (0.41) | OXER1ALOX5ACLYPLA2G4A | |
| SCHEMBL12476456 | 0.81 | OXER1 (0.32) | OXER1ALOX5PLA2G4A | |
| SCHEMBL12476453 | 0.81 | OXER1 (0.32) | OXER1ALOX5PLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130296436-A1 | AMIDINE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED | 2013-11-07 | — | — | US | disclosed |
| WO-2012090969-A1 | AMIDINE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296436-A1 | AMIDINE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL | C5, ATL3, C1S | OXER1 1321/4885ALOX5 1260/4885ACLY 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.